BRISTOL MYERS SQUIBB CO

Pharmaceutical Preparations·PRINCETON, NJ·FY end 12/31·CIK 14272

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
<UNKNOWN>	—	—	—	—	—	—
Adam LenkowskyEVP, Chief Commercialization Officer	$1.1M	$1.8M	—	$6.2M	$9.6M	—
Christopher S. BoernerPh.D. Board Chair and Chief Executive Officer	$1.6M	$3.8M	—	$16.5M	$21.9M	—
David V. ElkinsEVP and Chief Financial Officer	$1.1M	$1.8M	—	$6.2M	$9.2M	—
Greg MeyersEVP, Chief Digital and Technology Officer	$1.1M	$1.7M	—	$4.4M	$7.2M	—

Christopher S. Boerner · FY 2025

Stock awards$3.8M9%

Performance bonus$16.5M38%

Salary$1.6M4%

Other$21.9M50%

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY21

+3%

$7M

FY22

+23%

$11M

FY23

-9%

$0M

FY24

+5%

$21M

FY25

+5%

$17M

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.